Finding ways to link health care data in a secure and confidential way.
The strengths of blockchain technologies could help address the weaknesses of health care systems to store and secure medical records.
This African woman suffers from an autoimmune disease called vitiligo which causes the loss of skin pigment.
An autoimmune disease called vitiligo causes white spots to appear on the body, in some cases completely erasing an individual's pigmentation. But a new therapy is on the horizon.
Clinical trials involving probiotics are failing to report on the safety and harms of these treatments.
As medicines, not all cannabis products are created equal.
Everyone has to be vaccinated for immunisation programs to work.
Stating a majority of people won't benefit from a vaccine ignores the purpose of immunisation programs.
Clinical trials can bring important benefits to African countries.
African countries should be looking to initiate or host more clinical trials to improve the continent's health systems.
Reading over the consent form.
You should be aware of the amount of genetic information you might disclose in a research study – and what the benefits and risks will be.
Eczema, which is common in babies, is itchy and painful.
In this clinical trial, the first of its kind, physicians explore whether directly applying a 'good' strain of bacteria to the skin can heal eczema
There are currently no effective treatments for Alzheimer’s disease, which causes may elders to live their last years without recognizing their loved ones, and unable to care for themselves.
Study of the "memory centres" of the brain in adults offers hope for detecting Alzheimer's disease earlier -- before the onset of memory loss.
All multiple sclerosis sufferers have stem cells with the potential to heal them, but scientists are only just figuring out how to kick them into action.
Health Canada is proposing a new system to fast-track urgent drugs for children, the elderly and those with serious or life-threatening conditions. This would rely on decisions made by regulators in other jurisdictions.
Health Canada is proposing to allow some prescription drugs into the country with only 'cursory clinical review.' Here's why we should be worried.
Black mambas are extremely dangerous.
Coordinated international efforts may be key to improving the life expectancy and health of many snakebite victims.
Baroness Tessa Jowell speaking in the House of Lords.
There are several things we can do to speed up the development of new drugs, without putting patients at risk.
How a technology born from finance – the blockchain – can help the pharmaceutical industry to carry out clinical trials that protect patients.
The experimental technique of ‘deep brain stimulation’ has improved the lives of patients with treatment-resistant depression, despite the ‘failure’ of a large clinical trial.
For some patients, drilling a hole in the skull and inserting an electrode into the 'sadness centre' of the brain offers relief from debilitating and otherwise treatment-resistant depression.
Apple's Eyes Studio/Shutterstock.com
We need to ensure cancer research addresses what matters most.
Even if they are not treated, only about three per cent of men will die of prostate cancer over their lifetime, most in their 70s or 80s.
A family physician and public health researcher explains why he isn't getting a prostate cancer test in Movember or at any time in the near future.
A drug needs to pass quite a few hurdles before it gets to the market.
The Conversation/Wes Mountain
Only around 10% of new drugs in development make it onto the market. A drug needs to go through animal trials, and then four phases of human trials to be deemed suitable for use in patients.
Randomisation is the only commonly accepted method of ensuring an unbiased estimate of the treatment effect.
The Conversation/Wes Mountain
A randomised controlled trial is the best way to compare a new treatment with the standard treatment. And randomising trial participants is a core feature of the experiment.
It’s hard to test therapies for rare cancers because there are too few people to study.
Rare cancers are hard to research given the few patients that have each type of cancer, so how can we improve treatment for these patients?